Advertisement

Topics

Acorn Cardiovascular Company Profile

06:17 EDT 22nd October 2017 | BioPortfolio

Acorn Cardiovascular™ is a privately held medical device company that was incorporated in 1996 and is located in St. Paul, Minnesota, USA. Mission: Acorn Cardiovascular develops innovative solutions to successfully treat patients with heart failure and restore hope for a better, longer life. Background: Heart failure (HF) is a condition that is caused by damage to the heart muscle, which results in the inability of the heart to pump enough blood to meet the needs of the body. This highly debilitating and progressive disorder affects more than five million people in the United States and 25 million people worldwide. An estimated 550,000 new HF cases are diagnosed each year in the United States alone. Heart failure can be caused by or is the end result of a number of conditions, including coronary artery disease, prolonged high blood pressure, poor valve function or other cardiovascular abnormalities. CorCap™ Cardiac Support Device (CSD): The company’s introductory product, the CorCap™ Cardiac Support Device (CSD), is proprietary mesh wrap that is placed around the heart to provide gentle, permanent support. It is intended to prevent and reverse the progression of heart failure by improving the heart’s structure and function, leading to improvements in the quality of a patient’s life. The CorCap CSD received CE marking in September 2000. Randomized clinical trials evaluating effectiveness of the CorCap CSD have been completed in North America and Europe. The CorCap CSD has been used in the treatment of more than 460 patients worldwide.

Location

601 Campus Drive
St. Paul,
Minnesota
55112
United States of America

Contact

Phone: 651-286-4800
Fax: 651-286-4848
Email: info@acorncv.com


News Articles [428 Associated News Articles listed on BioPortfolio]

Takeda, Cardurion Pharmaceuticals partner on cardiovascular development

Takeda Pharmaceutical and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area based biotechnology company, is f...

Pericardial fat—not liver fat—associated with higher cardiovascular disease risk

Fat surrounding the

AUM Cardiovascular receives FDA clearance for diagnostic ECG system

AUM Cardiovascular has received clearance from the Food and Drug Administration (FDA) for its non-invasive acoustic and ECG device. The CADence device uses recorded sounds from a patient's heart and p...

Announcing the TCT 2017 press conference schedule

(Cardiovascular Research Foundation) The Cardiovascular Research Foundation (CRF) has announced the press conference schedule for late-breaking trials and first report investigations that will be pres...

Canagliflozin Reduces Cardiovascular Events in Diabetic Patients

Canagliflozin resulted in a lower risk of cardiovascular disease in type 2 diabetics who were at high cardiovascular risk. However, there was a higher risk of amputation, which is a new finding.

ADA 2017: Canagliflozin Significantly Reduces Risk of Cardiovascular Events

ArticleCanagliflozin (Invokana) significantly reduced the combined risk of cardiovascular death, myocardial infarction, and nonfatal stroke, versus placebo in patients with type 2 diabetes at risk for...

Sex-Specific Cardiovascular Drug Dosages Urged

NewsSex-specific cardiovascular drug dosages needed to reduce adverse reactions in women, according to the European Heart Journal - Cardiovascular Pharmacotherapy.

Announcing the TCT 2017 late-breaking trials and first report investigations

(Cardiovascular Research Foundation) The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 first report investigations that will be presented at the Transcathet...

PubMed Articles [1710 Associated PubMed Articles listed on BioPortfolio]

A cross-sectional examination of the profile of chiropractors recruited to the Australian Chiropractic Research Network (ACORN): a sustainable resource for future chiropractic research.

The Australian Chiropractic Research Network (ACORN) practice-based research network (PBRN) cohort was established to provide sustainable infrastructure necessary to address lack of rigorous investiga...

Antioxidant Extracts from Acorns (Quercus ilex L.) Effectively Protect Ready-to-Eat (RTE) Chicken Patties Irrespective of Packaging Atmosphere.

This study evaluated the impact of a phenolic-rich acorn extract (200 ppm gallic acid equivalents) and the concentration of oxygen in the packaging system (low-oxygen modified atmosphere; 5% vs. norma...

Acclimating to the Increase in Statin Use in Accountable Care Organizations Based on Changes in Quality Measures: A Report from the Accountable Care Organization Research Network, Services, and Education.

The Accountable Care Organization Research Network, Services, and Education (ACORN SEED), founded by faculty members at Nova Southeastern University College of Pharmacy, is a group of pharmacists that...

Drivers of synchrony of acorn production in the valley oak (Quercus lobata) at two spatial scales.

We investigated spatial synchrony of acorn production by valley oaks (Quercus lobata) among individual trees at the within-population, local level and at the among-population, statewide level spanning...

Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.

The need for novel approaches to cardiovascular drug development served as the impetus to convene an open meeting of experts from the pharmaceutical industry and academia to assess the challenges and ...

Clinical Trials [2400 Associated Clinical Trials listed on BioPortfolio]

Confirmation Trial of the Acorn CorCap Cardiac Support Device (CSD) at the Same Time as Mitral Valve Repair

The purpose of this study to evaluate patients when they have an Acorn CorCapTM Cardiac Support Device (CSD) placed around their heart for the treatment of heart failure at the same time a...

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)

This prospective, multi-center, observational study will assess the safety and efficacy of Avastin (bevacizumab) in daily practice in patients with metastatic colorectal cancer who have re...

Factors Influencing Cardiovascular Prognosis

The purpose of this study is to identify risks for cardiovascular events in a follow up period of 10 years.

Work Organization and Cardiovascular Disease

To determine the combined effects of job strain and social isolation on cardiovascular morbidity and mortality.

Role of Vitamin D in Secondary Prevention of Cardiovascular Events

The purpose of this study is to determine if Vitamin D supplementation helps prevent recurrent cardiovascular events, such as heart attack or stroke, in patients who have already experienc...

Companies [594 Associated Companies listed on BioPortfolio]

Acorn Systems

Acorn provides companies with profitability and cost management solutions to drive better business decisions. Combining proprietary technology with proven methodology, Acorn revea...

Acorn Cardiovascular

Acorn Cardiovascular™ is a privately held medical device company that was incorporated in 1996 and is located in St. Paul, Minnesota, USA. Mission: Acorn Cardiovascular develops innovative solutio...

ACORN Network

ACORN is a unique network of progressive community oncology clinics working together to change the paradigm of how clinical trials are implemented.

Acorn NMR Incorporated

Acorn NMR operates an NMR spectroscopy service with its modified NT 300 and 360 NMR instruments, operating at 300 and 360 MHz for protons. The majority of the NMR services provided are the basic one d...

Accelerated Community Oncology Research Network, Inc.

ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Contract Research Organization (CRO), providing contract and budgeti...

More Information about "Acorn Cardiovascular" on BioPortfolio

We have published hundreds of Acorn Cardiovascular news stories on BioPortfolio along with dozens of Acorn Cardiovascular Clinical Trials and PubMed Articles about Acorn Cardiovascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acorn Cardiovascular Companies in our database. You can also find out about relevant Acorn Cardiovascular Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record